Viewing Study NCT07077161


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2026-04-05 @ 3:13 PM
Study NCT ID: NCT07077161
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cabozantinib Dose Skipping as an Alternative to Dose Reductions
Sponsor: dr. Tom van der Hulle
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module